➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Merck
Moodys
Baxter

Last Updated: January 16, 2021

DrugPatentWatch Database Preview

Drugs with Dosage:

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drugs with Dosage:

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Fresenius Kabi Usa POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 211087-001 Sep 9, 2020 AP RX No No   Start Trial   Start Trial   Start Trial INJECTABLE;INJECTION
Fresenius Kabi Usa POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 211087-002 Sep 9, 2020 AP RX No No   Start Trial   Start Trial   Start Trial INJECTABLE;INJECTION
Fresenius Kabi Usa POTASSIUM CHLORIDE 20MEQ potassium chloride INJECTABLE;INJECTION 211087-003 Sep 9, 2020 AP RX No No   Start Trial   Start Trial   Start Trial INJECTABLE;INJECTION
Fresenius Kabi Usa POTASSIUM CHLORIDE 40MEQ potassium chloride INJECTABLE;INJECTION 211087-004 Sep 9, 2020 AP RX No No   Start Trial   Start Trial   Start Trial INJECTABLE;INJECTION
Glaxosmithkline TRELEGY ELLIPTA fluticasone furoate; umeclidinium bromide; vilanterol trifenatate POWDER;INHALATION 209482-002 Sep 9, 2020 RX Yes Yes   Start Trial   Start Trial   Start Trial POWDER;INHALATION
Glaxosmithkline TRELEGY ELLIPTA fluticasone furoate; umeclidinium bromide; vilanterol trifenatate POWDER;INHALATION 209482-002 Sep 9, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial POWDER;INHALATION
Glaxosmithkline TRELEGY ELLIPTA fluticasone furoate; umeclidinium bromide; vilanterol trifenatate POWDER;INHALATION 209482-002 Sep 9, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial POWDER;INHALATION
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Boehringer Ingelheim
Dow
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2021 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2021 - 2022
 NCE-1 Patent Challenge Dates 2021 - 2022
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group